Australia markets closed

QURE Jan 2025 7.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
0.82000.0000 (0.00%)
As of 01:49PM EDT. Market open.
Full screen
Previous close0.8200
Open0.9000
Bid0.0000
Ask3.7000
Strike7.00
Expiry date2025-01-17
Day's range0.8200 - 0.9000
Contract rangeN/A
Volume8
Open interest2.77k
  • Simply Wall St.

    uniQure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

    uniQure ( NASDAQ:QURE ) First Quarter 2024 Results Key Financial Results Revenue: US$8.49m (up 59% from 1Q 2023). Net...

  • GlobeNewswire

    uniQure Announces First Quarter 2024 Financial Results and Highlights Recent Company Progress

    ~ On track to initiate FDA interaction regarding AMT-130 in second quarter of 2024 and provide a clinical update from the Phase I/II trials in mid-2024 ~ ~ Clinical trial initiation for Fabry disease on track to begin in second quarter of 2024, followed by refractory mesial temporal lobe epilepsy and SOD1-ALS in third quarter of 2024 ~ ~ Comprehensive review of operations and options to reduce expenses underway and expected to be completed in mid-2024 ~ LEXINGTON, Mass. and AMSTERDAM, May 07, 20

  • Insider Monkey

    13 Best Biotech Stocks To Buy Under $20

    In this article, we’re going to take a look at 13 best biotech stocks to buy under $20. To see more stocks that made the list, you can skip ahead and jump straight to the top 5 best biotech stocks to buy under $20. When it comes to investing, few industries are as exciting to […]